These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20879858)

  • 1. Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.
    Rotger M; Gsponer T; Martinez R; Taffé P; Elzi L; Vernazza P; Cavassini M; Bernasconi E; Hirschel B; Furrer H; Weber R; Ledergerber B; Egger M; Telenti A; Tarr PE;
    Clin Infect Dis; 2010 Nov; 51(9):1090-8. PubMed ID: 20879858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
    Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
    Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
    Schoepf IC; Thorball CW; Ledergerber B; Engel T; Raffenberg M; Kootstra NA; Reiss P; Hasse B; Marzolini C; Thurnheer C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos R; Günthard HF; Fellay J; Tarr PE;
    Clin Infect Dis; 2021 Nov; 73(9):1597-1604. PubMed ID: 34091660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus burden among people living with HIV from the Asia-Pacific region.
    Han WM; Jiamsakul A; Kiertiburanakul S; Ng OT; Sim BL; Sun LP; Van Nguyen K; Choi JY; Lee MP; Wong WW; Kamarulzaman A; Kumarasamy N; Zhang F; Tanuma J; Do CD; Chaiwarith R; Merati TP; Yunihastuti E; Pujari S; Ditangco R; Khusuwan S; Ross J; Avihingsanon A;
    J Int AIDS Soc; 2019 Jan; 22(1):e25236. PubMed ID: 30697944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.
    Tarr PE; Rotger M; Telenti A
    Pharmacogenomics; 2010 Apr; 11(4):587-94. PubMed ID: 20350140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
    Rotger M; Glass TR; Junier T; Lundgren J; Neaton JD; Poloni ES; van 't Wout AB; Lubomirov R; Colombo S; Martinez R; Rauch A; Günthard HF; Neuhaus J; Wentworth D; van Manen D; Gras LA; Schuitemaker H; Albini L; Torti C; Jacobson LP; Li X; Kingsley LA; Carli F; Guaraldi G; Ford ES; Sereti I; Hadigan C; Martinez E; Arnedo M; Egaña-Gorroño L; Gatell JM; Law M; Bendall C; Petoumenos K; Rockstroh J; Wasmuth JC; Kabamba K; Delforge M; De Wit S; Berger F; Mauss S; de Paz Sierra M; Losso M; Belloso WH; Leyes M; Campins A; Mondi A; De Luca A; Bernardino I; Barriuso-Iglesias M; Torrecilla-Rodriguez A; Gonzalez-Garcia J; Arribas JR; Fanti I; Gel S; Puig J; Negredo E; Gutierrez M; Domingo P; Fischer J; Fätkenheuer G; Alonso-Villaverde C; Macken A; Woo J; McGinty T; Mallon P; Mangili A; Skinner S; Wanke CA; Reiss P; Weber R; Bucher HC; Fellay J; Telenti A; Tarr PE; ; ;
    Clin Infect Dis; 2013 Jul; 57(1):112-21. PubMed ID: 23532479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
    Dietrich LG; Barceló C; Thorball CW; Ryom L; Burkhalter F; Hasse B; Furrer H; Weisser M; Steffen A; Bernasconi E; Cavassini M; de Seigneux S; Csajka C; Fellay J; Ledergerber B; Tarr PE
    Clin Infect Dis; 2020 Feb; 70(5):890-897. PubMed ID: 30953057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD; Mathiesen ER; Kronborg G; Pedersen C; Gerstoft J; Obel N
    PLoS One; 2012; 7(9):e44575. PubMed ID: 22984529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study.
    Lin SP; Wu CY; Wang CB; Li TC; Ko NY; Shi ZY
    Medicine (Baltimore); 2018 Sep; 97(36):e12268. PubMed ID: 30200166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter cohort study of diabetes mellitus and impaired fasting glucose in HIV-infected patients in China.
    Zhang C; Chow FC; Han Y; Xie J; Qiu Z; Guo F; Li Y; Wang H; Li T
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):298-303. PubMed ID: 25469524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Incident Diabetes Mellitus, Weight Gain, and Their Relationships With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among Persons With Human Immunodeficiency Virus in the United States and Canada.
    Rebeiro PF; Jenkins CA; Bian A; Lake JE; Bourgi K; Moore RD; Horberg MA; Matthews WC; Silverberg MJ; Thorne J; Mayor AM; Lima VD; Palella FJ; Saag MS; Althoff KN; Gill MJ; Wong C; Klein MB; Crane HM; Marconi VC; Shepherd BE; Sterling TR; Koethe JR
    Clin Infect Dis; 2021 Oct; 73(7):e2234-e2242. PubMed ID: 32936919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.
    Petoumenos K; Worm SW; Fontas E; Weber R; De Wit S; Bruyand M; Reiss P; El-Sadr W; Monforte AD; Friis-Møller N; Lundgren JD; Law MG;
    J Int AIDS Soc; 2012 Oct; 15(2):17426. PubMed ID: 23078769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical outcomes of diabetes mellitus in HIV-infected adults in Thailand: a retrospective cohort study.
    Paengsai N; Jourdain G; Chaiwarith R; Tantraworasin A; Bowonwatanuwong C; Bhakeecheep S; Cressey TR; Mary JY; Salvadori N; Kosachunhanun N
    BMC Public Health; 2018 Aug; 18(1):1079. PubMed ID: 30165821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of HIV infection with incident diabetes mellitus: impact of using hemoglobin A1C as a criterion for diabetes.
    Tien PC; Schneider MF; Cox C; Karim R; Cohen M; Sharma A; Young M; Glesby MJ
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):334-40. PubMed ID: 22878421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
    Ledergerber B; Furrer H; Rickenbach M; Lehmann R; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Egger M; Weber R;
    Clin Infect Dis; 2007 Jul; 45(1):111-9. PubMed ID: 17554711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.
    Tien PC; Schneider MF; Cole SR; Levine AM; Cohen M; DeHovitz J; Young M; Justman JE
    AIDS; 2007 Aug; 21(13):1739-45. PubMed ID: 17690572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.
    Tripathi A; Liese AD; Jerrell JM; Zhang J; Rizvi AA; Albrecht H; Duffus WA
    Diabet Med; 2014 Oct; 31(10):1185-93. PubMed ID: 24673640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
    Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS
    Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates and drivers of progression to pre-diabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a global systematic review and meta-analysis protocol.
    Nansseu JR; Bigna JJ; Kaze AD; Noubiap JJ
    BMJ Open; 2016 Sep; 6(9):e012852. PubMed ID: 27633645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.
    Echecopar-Sabogal J; D'Angelo-Piaggio L; Chanamé-Baca DM; Ugarte-Gil C
    Int J STD AIDS; 2018 Apr; 29(5):443-452. PubMed ID: 28956700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.